Veriheal

JANUARY 11, 2023

Gaize is mastering the art of cannabis impairment detection. The Missoula, Montana-based company is gearing up for the launch of its first science-backed real-time cannabis impairment detection device. Studies on cannabis have shown that the plant may cause disorientation, sedation, lack of concentration, and impaired judgment.

Clinical Trials 98

Clinical Trials THC Data Safety 98

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. Virtual Clinical Trials transcend geographic, mobility and economic barriers. Authored By : Arundati Dandapani.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

JULY 7, 2021

The Canadian weed giant marked a milestone in Germany this week, harvesting the country’s first medical cannabis crop. Tilray is embarking on a push to educate more German doctors about the benefits of prescribing medical cannabis, as the weed giant seeks to cement its dominance in the highly-profitable European medical market.

Clinical Trials 105

Clinical Trials Education Data Pharmaceutical 105

Veriheal

MAY 26, 2022

With new and improved products popping up left and right, legalization initiatives taking off all over the globe, and harmful “stoner” stigmas quickly dissipating, it’s clear that cannabis has entered a new era. The days of “reefer madness” are long over, replaced by a growing acknowledgment of the cannabis plant’s therapeutic abilities.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

AUGUST 7, 2021

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Key Responsibilities.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

CannaMD

JUNE 2, 2021

However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms. In addition, cannabis users participating in the survey were younger by an average of 3 years in age than non-users in the survey. Why Do Parkinson’s Patients Use Marijuana?

Patients 105

Patients Clinical Trials Treatment Research and Development 105

The Cannigma

OCTOBER 14, 2022

Recreational cannabis is not legal, despite a 2019 citizen’s initiative that called for legalization. In 2019 the Parliament approved a citizen’s proposal to regulate recreational use of cannabis, but backtracked in March 2020 , saying they would wait to follow the lead of Italy. Can you bring or buy cannabis products?

Law 56

Law Clinical Trials Research and Development Recreational 56

Veriheal

AUGUST 31, 2020

At Veriheal, education and diversity are at the center of our core values. Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. .

Research and Development 117

Research and Development Education Agriculture Patients 117

NewsMunchies

NOVEMBER 12, 2021

As the cannabis industry continues to grow and evolve with legalization achieved in many parts of the world, we’re seeing an increase in activity related to another substance that will hopefully be removed from the list of controlled substances – psilocybin. Additional clinical trials underway in the U.S.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

Cannabis Life Network

MAY 27, 2021

Early scientific research and clinical trials have shown promise in their ability to help supplement treatments for people with various neurological disorders with cannabidiol (CBD). CBD is a naturally occurring chemical compound found in cannabis, such as hemp.

Clinical Trials 76

Clinical Trials CBD Treatment Hemp 76

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge. We have a ways to go,” Tan said.

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. in each of the four validation trials with an acceptable yield, which is a noteworthy accomplishment.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

AUGUST 10, 2022

MediPharm to design, manufacture and supply a liquid oral cannabis study drug for the Phase 2 Life’s end Benefits of cannabidiol and tetrahydrocannabinol (LiBBY) study, to be conducted in the U.S., ” Study Details – provided by Alzheimer’s Clinical Trial Consortium. across 20 sites. MediPharm Labs Corp.

Clinical Trials 52

Clinical Trials Medicine Pharmaceutical THC 52

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Drugs: Education, Prevention and Policy , 28 (3), 211–214. Madison Natarajan, MS. – August 5, 2021. Thrul, J., & Garcia-Romeu, A. link] (Link). Source: [link].

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Cannabis Law Report

JULY 27, 2021

The ORR is a web-based research platform open to adults and adult caregivers of dependents who are, or are considering, the use of cannabis or hemp products for therapeutic purposes. There are numerous obstacles to exploring the therapeutic potential of cannabis due to its classification as a Schedule I controlled substance,” Schlienz said.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

JANUARY 19, 2022

Congressman Moran introduced the AUTISM Educators Act in 2012, which funded partnerships between public schools and higher education and non-profit organizations to promote teaching skills for educators working with high functioning autism students. The Company also operates an infrastructure business based in India.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

FloridaMarijuana.net

AUGUST 16, 2018

The clinical trials for medications take years and to this date, there have been no effective medications to properly treat and/or cure Dementia. Within the past 30 years, there has been an increase in substantial research which supports cannabis as a medical intervention.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Cannabis Law Report

DECEMBER 9, 2021

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Veriheal

MAY 12, 2021

The relationship between cannabis and cancer has long been at the forefront of research regarding its medical efficacy, mainly for legalization and treatment purposes. However, cannabis use amongst those with cancer is poorly understood, at least according to a team of researchers. years old.

Patients 98

Patients Consumption Clinical Trials Education 98

Cannabis Law Report

OCTOBER 2, 2021

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

Cannabis Law Report

MAY 28, 2022

The firm represents clients around the world in major industries including energy and natural resources; financial services and capital markets; food and agribusiness; healthcare, life sciences and education; real estate, development and construction; and technology, manufacturing and transportation.

Research and Development 52

Research and Development Therapy Clinical Trials Legalization 52

Cannabis Law Report

JUNE 29, 2021

Synergetic Press and the Multidisciplinary Association for Psychedelic Science (MAPS) are pleased to announce they have entered into a copublishing relationship effective May 1, 2021 which will greatly expand the availability of education about psychedelics and psychedelic therapy. founder and executive director of MAPS.

Therapy 90

Therapy Research and Development Clinical Trials Education 90

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

SEPTEMBER 23, 2022

Going forward, MAPS will focus on advocating for psychedelic policy reform to include state funding for public education, harm reduction, and unarmed crisis response services. MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD. ABOUT MAPS.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

SpeedWeed

SEPTEMBER 17, 2021

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. On August 10, MAPS was awarded a $12,979,050 grant from the state of Michigan to fund a study on post-traumatic stress disorder ( PTSD ) and cannabis.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

AUGUST 21, 2019

PUBLISHER: CANNABIS LAW REPORT. Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said the children’s experiences on medicinal cannabis in the should be taken into account as evidence of how well the drug works. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

CannaTech

SEPTEMBER 16, 2018

Changing Cannabis Conversations Worldwide. Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. While Canada’s medicinal cannabis framework has gone through many iterations, Canada has led the way in showing to the world how to think about cannabis.

Education 66

Education Medicine Clinical Trials Patients 66

SpeedWeed

AUGUST 16, 2021

LAS VEGAS, NV [August 16, 2021] – Cannabis Conference , produced by parent company GIE Media Inc. Dr. Sisley will highlight cutting-edge discoveries from her roles in cannabis studies for pain management and post-traumatic stress disorder (PTSD), as a substitution therapy for opioids, and more. About Cannabis Conference.

Media 52

Media Clinical Trials DEA Hemp 52

Cannabis Law Report

DECEMBER 9, 2021

MAPS Founded in 1986, MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Healer

MARCH 26, 2021

Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. March 19, 2021.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

JULY 28, 2021

We believe in diversity and inclusion of people of all backgrounds, genders, races, ethnicities, sexual orientations, educational backgrounds, military and veteran status,?religions, 2-3 years of relevant experience in clinical trials, research methods, or statistical design and analysis. religions, abilities, and perspectives.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. Certainly, it is likely that some who pursue a facilitator license will have advanced education and/or credentials in a health care specialty.

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

MARCH 23, 2023

One of the proposed bills would amend the Cannabis Control Law during the current 150-day Diet session, which launched on Monday, January 23. Based on Japan’s Cannabis Control Law—A.K.A. Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products. ‘1948 Law No.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

FloridaMarijuana.net

JUNE 13, 2018

For centuries, humans have relied on the cannabis plant for its therapeutic properties. More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to cancer treatments. Cannabis has given cancer patients relief , improved their mood and anxiety, and relieved insomnia.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Cannabis Law Report

OCTOBER 17, 2019

The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. POPLAR is the first academic initiative focused on psychedelics law and policy, positioned to be a global leader for research and education in this space. Background. The Project.

Law 59

Law Policy Research and Development Clinical Trials 59